Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Other Accumulated Expenses (2024 - 2025)

Metagenomi (MGX) has disclosed Other Accumulated Expenses for 2 consecutive years, with $312000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $312000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $312000.0, a N/A change, with the full-year FY2024 number at $446000.0, changed N/A from a year prior.
  • Other Accumulated Expenses was $312000.0 for Q3 2025 at Metagenomi, up from $276000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $446000.0 in Q4 2024 to a low of $117000.0 in Q1 2025.